The Brief Cognitive Assessment Tool (BCAT): A New Test Emphasizing Contextual Memory and Executive Functions Drs. William Mansbach, Elizabeth MacDougall,

Slides:



Advertisements
Similar presentations
Psychological Assessment
Advertisements

It is common practice for Neuropsychologists to administer the same tests on more than one occasion to document the progression of a patient’s cognitive.
Epidemiological study of mild cognitive impairment and pilot evaluation of methods of early dementia detection in Chinese community Yueqin Huang MD MPH.
MemTrax (Computerized Memory Screen) American Association of Geriatric Psychiatry (AAGP) March 2, 2007 J. Wesson Ashford, M.D., Ph.D. Stanford / VA Aging.
VAMC St Louis University Mental Status Examination - SLUMS
DRAFT Promotional Copy for NNSDO 1 Cognitive / Mental Status Assessment of Older Adults.
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 12 Measures of Association.
Neuropathology and Cognitive Scores Workgroup The role of vascular and Alzheimer’s Disease pathology in differential cognitive impairment among older adults.
Screening for Alzheimer’s disease Herman Buschke, MD Einstein Aging Study (NIA AG-03949) Department of Neurology Albert Einstein College of Medicine.
Brief Cognitive Assessment Tool (BCAT®) Training Program
Tony WAEGEMANS, MD UCB Pharma, Belgium. TW/ll/ Washington/MCI 2 MCI as implemented in our study MCI is a very early stage of dementia with as main.
Mary Ganguli’s Slides March 13 th Meeting. Mild Cognitive Impairment A View from the Trenches.
Screening By building screening for symptoms of VCI into regular workflows or practice, health care providers are participating in Taking Action to address.
The New Brief Cognitive Assessment Tool (BCAT): The Role of Cognitive Assessment in Improving Health Outcomes Dr. William Mansbach October 25, 2011.
Mild Cognitive Impairment as a Target for Drug Development Steven H. Ferris, Ph.D. Silberstein Aging and Dementia Research Center New York University School.
ACT on Alzheimer’s Disease Curriculum Module VI: Screening.
ACT on Alzheimer’s Disease Curriculum Module VII: Disease Diagnosis.
MCI Clinical Trial Design FDA Advisory Committee Meeting March 13, 2001 Gaithersburg, MD Michael Grundman, MD, MPH Alzheimer’s Disease Cooperative Study.
Author: Sabrina Hinton. Year and Publisher: American Guidance Service.
Measurement Concepts & Interpretation. Scores on tests can be interpreted: By comparing a client to a peer in the norm group to determine how different.
Screening for Stroke and Cognitive Impairment Chapter 2: Background.
Copyright © 2001 by The Psychological Corporation 1 The Academic Competence Evaluation Scales (ACES) Rating scale technology for identifying students with.
© 2013 Cengage Learning. Outline  Types of Cross-Cultural Research  Method validation studies  Indigenous cultural studies  Cross-cultural comparisons.
Educational level relative to gender (Ν=28)
Instrumentation.
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 14 Measurement and Data Quality.
Screening for Stroke and Cognitive Impairment Chapter 5: When is Cognitive Screening Limited?
VAMC/ST LOUIS UNIVERSITY
Introduction Multiple Sclerosis (MS) is a chronic inflammatory disease characterized by the demyelization of axons within the central nervous system (CNS).
ACT on Alzheimer’s Disease Curriculum Module V: Cognitive Assessment and the Value of Early Identification.
WHAT WE LEARNED In a clinically-referred, assisted living sample: 1.NAB Judgment (NAB-JDG) scores displayed good internal consistency reliability. 2.NAB-JDG.
BY DR ZAINAB ABDULZAEEZ UMAR DEPARTMENT OF FAMILY MEDICINE AMINU KANO TEACHING HOSPITAL.
MGTO 324 Recruitment and Selections Validity I (Construct Validity) Kin Fai Ellick Wong Ph.D. Department of Management of Organizations Hong Kong University.
EVIDENCE ABOUT DIAGNOSTIC TESTS Min H. Huang, PT, PhD, NCS.
Competency in Older Adults: Clinical and Legal Perspectives The Role of Cognitive and Neuropsychological Evaluations John Crumlin, PhD Assistant Director,
Growth in Reading Curriculum – Based Measures and Predicting High Stakes Outcomes.
Value of Cognitive Assessment and Brain Fitness for Improving Memory and Preventing Behavioral Disturbances Presented by Susan Kraus, MSN, CRNP-PMH, CRNP-A.
MINI MENTAL STATUS EXAMINATION (MMSE) PREPARED BY DR. IRENE ROCO ASST. PROFESSOR.
Do Instrumental Activities of Daily Living Predict Dementia at 1- and 2- Year Follow-Up? Findings from the Development of Screening Guidelines and Diagnostic.
Friday Harbor Psychometrics 2012 Scientific Summary UC Davis / SENAS (Spanish and English Neuropsychological Assessment Scales)
Multitrait Scaling and IRT: Part I Ron D. Hays, Ph.D. Questionnaire Design and Testing.
Psychometrics. Goals of statistics Describe what is happening now –DESCRIPTIVE STATISTICS Determine what is probably happening or what might happen in.
Reliability and validity of the adapted Spanish version of the Early Onset Scoliosis-24 questionnaire María del Mar Pozo-Balado, PhD Hiroko Matsumoto PhD.
10 May Understanding diagnostic tests Evan Sergeant AusVet Animal Health Services.
The Alzheimer’s Disease Challenge: Take Your Knowledge Further ALZHEIMER’S DISEASE AND ITS MANAGEMENT: AN OVERVIEW.
Additional Assessments. Clinicians are encouraged to communicate with the interprofessional team about other resources and next steps in terms of additional.
NON PHARMACOLOGICAL THERAPY OF MENTAL IMAGERY AND RELAXATION IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT Poptsi Ε.,1,3, Κounti F.,1,3,Τsolaki, Μ. 1,2 1.
Mild Cognitive Impairment, Activity Participation, Functional Difficulty, and Adaptations in Functionally Vulnerable Elderly People: A Closer Look Laraine.
Mild Cognitive Impairment (MCI) Screening Tools for Primary Care Providers Jamila Hussain, PGY-3 Faculty Development Cook County-Loyola-Provident Family.
The Process of Psychometric Validation of an Instrument across Language and Culture Halfway around the World Huey-Shys Chen PhD, RN, CHES Assistant Professor,
Cognitive Testing, Statistics and Dementia Ralph J. Kiernan Ph.D. 14 th May 2013.
The diagnosis of dementia - 2
The Clinical Utility of the LANSE- A and LANSE-C Jennifer L. Harrison, M.A., Megan Pollock, M.A., Amy Mouanoutoua, M.A. Ashley Brimager, M.A., & Paul C.
Results Results Dillon C, MD, PhD; Vazquez G, MD, PhD ; Corrales A, MD; Allegri RF, MD, PhD; Taragano FE, MD, PhD. CEMIC University Hospital, SIREN, Department.
Mental Health Problems and Treatment Among Older Adults in Latin America and the Caribbean Elizabeth M Bertera, PhD, LCSW-C, BCD Associate Professor of.
Memory and Aging Educational Presentation Presented by Tessa Lundquist, M.S. University of Massachusetts Amherst.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 25 Critiquing Assessments Sherrilene Classen, Craig A. Velozo.
Identifying Medically At-Risk Drivers Older Driver Safety Summit Planning a Safe and Mobile Future for Massachusetts Ann Hollis, OTR/L Beth Israel Deaconess.
Aka STEEL VALLEY SENIORS SURVEY (SVSS)
Rachel L. Fazio, Psy. D. , Allison N. Faris, Psy. D. , Karim Z
Posttraumatic Stress Disorder Checklist (PCL)
What is the MoCA? Screening for VCI should be conducted using a validated screening tool, such as the Montreal Cognitive Assessment test. Additional screening.
Spanish and English Neuropsychological Assessment Scales - Guiding Principles and Evolution Friday Harbor Psychometrics Workshop 2005.
Pediatric HITSS (PedHITSS)
Mini-Mental State Examination - 2nd Edition
Interreg-IPA Cross-border Cooperation Programme Romania-Serbia
MCI Today, Dementia Tomorrow: Improving Clinical Strategies
Statistically-Derived Subtypes and Associations with Cerebrospinal Fluid and Genetic Biomarkers in Mild Cognitive Impairment: A Latent Profile AnalysiS.
Fig. 1. ROC curve for K-IADL to diagnose dementia or MCI
Presentation transcript:

The Brief Cognitive Assessment Tool (BCAT): A New Test Emphasizing Contextual Memory and Executive Functions Drs. William Mansbach, Elizabeth MacDougall, & Andrew Rosenzweig November 22, 2011

Dementia Facts Over 65 population projected to double from 36 million in 2003 to 72 million in 2030, and will increase from 12% to 20% of the total population Over 85 population also projected to double from 4.7 million in 2003 to 9.6 million in 2030 Alzheimer’s disease (AD) affects over 5 million Americans, with people 85 and older at the highest risk It is estimated that by 2050, 13 million Americans will have AD Current prevalence rates of dementia in SNF and ALF is at or above 50% Estimated cumulative costs associated with AD alone will exceed $20 trillion between 2010 and 2050

Mini-Mental State Examination (MMSE) Short Test of Mental Status (STMS) Montreal Cognitive Assessment (MoCA) St. Louis University Mental Status Examination (SLUMS) Brief Interview for Mental Status (BIMS) Why a New Cognitive Screening Tool?

Cognitive screening measures can be enhanced if they: can be administered by paraprofessionals and clinicians alike; can be completed in approximately minutes; can differentiate among MCI, mild dementia and moderate dementia; contain a strong, multi-level verbal memory component; have a broadly complex executive function component, and predict IADL performance.

Validate a new cognitive test Determine if the BCAT yields statistically robust Contextual Memory and Executive Functions clusters Determine if the BCAT is predictive of IADLs BCAT Reliability & Validity Study Study Objectives

111 Participants Largely from ALF IRB-approved study Participants referred to Memory Center for comprehensive neuropsychological evaluation Psychologists expert in dementia made CDR DX classifications without reference to BCAT scores Demographics: Ages 61-97, 88% Caucasian, 75% widowed, 75% 12/+ education 67% demented, 33% non-demented BCAT Reliability & Validity Study Method

BCAT Reliability & Validity Study Method, continued Select Demographic Characteristics and Diagnoses of Participants

BCAT Reliability & Validity Study Method, continued Select Demographic Characteristics and Diagnoses of Participants

BCAT Reliability & Validity Study Method, continued Select Demographic Characteristics and Diagnoses of Participants

BCAT Reliability & Validity Study Method, continued Select Demographic Characteristics and Diagnoses of Participants

Average inter-item correlation for the BCAT was.36 Internal consistency reliability, as estimated by Cronbach’s α based on standardized items, was.92. Test-retest reliability was r =.99. Convergent validity was demonstrated by the significant correlation of the BCAT with the MMSE, r s =.90, p<.001, and with the STMS, r =.84, p<.001. Discriminant validity was demonstrated by the absence of a relationship between the BCAT and the GDS, r s = -.08 (n = 66; median GDS score = 5.0). BCAT Reliability & Validity Study Results

Additional evidence of construct validity was demonstrated by the significant correlation of the BCAT with several measures of functioning and judgment, including the NAB Judgment scale BCAT mean scores were significantly different across the three diagnostic categories (i.e., MCI, mild dementia, moderate dementia), F(2, 94) = 82.03, p<.001, ω 2 =.63 Post-hoc (Bonferroni) analysis revealed significant BCAT mean score differences for MCI vs. mild dementia, p<.001, MCI vs. moderate dementia, p<.01, and for mild dementia vs. moderate dementia, p<.001 BCAT Reliability & Validity Study Results, continued

BCAT Scores by Diagnostic Category BCAT Reliability & Validity Study

The predictive validity of the BCAT was addressed with analyses of sensitivity, specificity, positive predictive value, and negative predictive value. The area under the ROC curve for the BCAT was.95, p<.001, 95% CI [.91, 1.00]. A BCAT cut-score of 38 yielded maximum sensitivity, with a PPV of.91, indicating a 91% likelihood of correctly diagnosing dementia. The NPV of.96 indicates a 96% probability of correctly determining that one does not have dementia. BCAT Reliability & Validity Study Results, continued

Regression analyses provided further evidence of the predictive validity of the BCAT. The BCAT total score was a significant predictor of basic and instrumental ADLs, as measured by the PSMS (ß= -.41, p<.001), and the Lawton IADL scale (ß=.63, p<.001) The 3 “clusters” were found to be predictive of diagnostic category and the IADL measure BCAT Reliability & Validity Study Results, continued

Predictive Utility of Several BCAT Cut Scores BCAT Reliability & Validity Study a BCAT cut-scores to classify participants into dementia /MCI diagnostic categories b 95% confidence interval in parentheses

BCAT Reliability & Validity Study | Principal Component Analysis: 3 Clusters Item1 23 Story Recognition.76 Delayed Story Recall.74 Immediate Story Recall.64 Orientation.62 Mental Control #1 Verbal Traits.81 Mental Control #2.63 Judgment.60 Digits Backward.55 Arithmetic Reasoning.55 Immediate Word-List Recall.75 Naming.67 Letter List.61 Language Repetition Summary of exploratory principal components analysis results for the BCAT (N = 104) Rotated Factor Loadings

BCAT: The 3 Clusters 1. Contextual Memory Immediate Story Recall Delayed Story Recall Story Recognition Orientation example “Carol borrowed $10 from her brother Jack last week. She couldn’t pay him back because she bought a delicious ice cream cone at the circus.”

BCAT: The 3 Clusters 2. Executive Functions Verbal Trails (OTMT) Mental Control (days of the week, backward) Judgment Arithmetic Reasoning Digits Backward example “Suppose you have a 1 PM appointment with your doctor. It takes 45 minutes to get there. What time is the latest you can leave to get there at 1 PM?”

BCAT: The 3 Clusters 2. Executive Functions Verbal Trails (OTMT) Mental Control (days of the week, backward) Judgment Arithmetic Reasoning Digits Backward example “You have $25 to spend at the grocery store. You buy milk for $3. You buy 2 apples for a $1. How much money do you have left?”

BCAT: The 3 Clusters 3. Attentional Capacity Immediate Word List Naming Letter List example Banana… Justice… Sara… Bridge…

Contextual Memory: utility of Story Recall, especially Story Recognition Immediate Word List recall: attention versus memory Executive Functions: utility of OTMT (Verbal Trails) Clinical considerations: “Cut” score Caution in generalizing Screening results require confirmation BCAT Reliability & Validity Study Discussion

The Brief Cognitive Assessment Tool (BCAT) Key Characteristics Can be administered by professionals and paraprofessionals 21 items, 50-point scale Can be administered in minutes Has a “cut” score separating dementia from Mild Cognitive Impairment (MCI) Has scores ranges for MCI, mild dementia, & moderate dementia Contains a multi-level verbal memory component Contains a broadly complex executive functions component Predicts Instrumental Activities of Daily Living (IADL) The BCAT website has an automated scoring program

Introducing the BCAT Website –

“Cut” score separating dementia from Mild Cognitive Impairment is 37/38 How to interpret the Contextual Memory Cluster How to interpret the Executive Functions Cluster How to interpret the Attentional Capacity Cluster Interpreting BCAT Scores

Mansbach, W. E., MacDougall, E. E., & Rosenzweig, A. S. (in press). The Brief Cognitive Assessment Tool (BCAT): A new test emphasizing contextual memory, executive functions, attentional capacity, and the prediction of instrumental activities of daily living. Journal of Clinical and Experimental Neuropsychology. Published BCAT Research

William E. Mansbach, Ph.D. Founder and CEO, Mansbach Health Tools, LLC Chief Operating Officer, MedOptions thebcat.com (443)